BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
AstraZeneca
McKinsey
Farmers Insurance
US Army
Fish and Richardson
Deloitte
Moodys

Generated: January 19, 2018

DrugPatentWatch Database Preview

GLYCOLAX Drug Profile

« Back to Dashboard

When do Glycolax patents expire, and what generic alternatives are available?

Glycolax is a drug marketed by Kremers Urban Pharms and is included in two NDAs.

The generic ingredient in GLYCOLAX is polyethylene glycol 3350. There are four hundred and seventeen drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350 profile page.
Drug patent expirations by year for GLYCOLAX
Pharmacology for GLYCOLAX

US Patents and Regulatory Information for GLYCOLAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kremers Urban Pharms GLYCOLAX polyethylene glycol 3350 FOR SOLUTION;ORAL 076652-001 Jul 2, 2004 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kremers Urban Pharms GLYCOLAX polyethylene glycol 3350 FOR SOLUTION;ORAL 090600-001 Oct 6, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kremers Urban Pharms GLYCOLAX polyethylene glycol 3350 FOR SOLUTION;ORAL 090600-002 Oct 6, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Accenture
Federal Trade Commission
McKesson
US Department of Justice
Daiichi Sankyo
US Army
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot